News
2d
Zacks Investment Research on MSNHims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock of late, since ...
4d
Stocktwits on MSNHims & Hers Stock Sparks Retail Trader Frenzy After CEO Announces 'Largest Raise Yet' Of $1BShares of Hims & Hers Health, Inc. (HIMS) surged nearly 16% in Tuesday’s regular session and extended gains in after hours ...
Online health and wellness company Hims & Hers raised $1 billion through convertible senior notes to grow its international ...
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible ...
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.
Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...
Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
In this week’s edition of InnovationRx, we look at Trump's drug pricing executive order, how the cofounder of Hims became a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results